Farewell to Sahin and Türeci: A Wise Decision by the BioNTech Founders
Ugur Sahin and Özlem Türeci, founders of BioNTech, are stepping back from daily operations, a decision viewed as part of their strategic foresight.
Farewell to Sahin and Türeci: A Wise Decision by the BioNTech Founders
Ugur Sahin and Özlem Türeci's decision to step back from the operational leadership of BioNTech is seen as a strategic move in their ongoing legacy in pharmaceuticals.
Biontech: 'Heart and Brain'
Uğur Şahin and Özlem Türeci, the co-founders of Biotech company Biontech, will step down from their executive roles at the end of 2026 to start a new venture focused on mRNA and AI.
The two founders of BioNTech leave the pharmaceutical company that won the race for COVID vaccines
The founders of BioNTech, Ugur Sahin and Özlem Türeci, are leaving the company to create a new venture focused on next-generation mRNA medications.
End of an Era at BioNTech: Turkish Co-Founders Depart
The co-founders of BioNTech, Ugur Sahin and Özlem Türeci, are leaving the company to pursue a new venture focusing on next-generation mRNA technology amid rising financial losses for BioNTech.
Pharmaceutical Industry: BioNTech Founders Leave Company
BioNTech founders Uğur Şahin and Özlem Türeci will leave the company by the end of 2026 to start a new biotechnology firm focused on developing the next generation of mRNA-based drugs, while remaining shareholders in BioNTech.
Pharmaceutical industry: BioNTech founders leave the company
BioNTech founders Uğur Şahin and Özlem Türeci will leave the company by the end of 2026 to establish a new biotechnology firm focused on mRNA-based medications while retaining a minority stake in BioNTech.
Pharma Pioneers: Founders Ugur Sahin and Özlem Türeci Leave Biontech
Biontech founders Ugur Sahin and Özlem Türeci are set to leave the company to start a new biopharmaceutical venture focusing on mRNA-based medications.